|1.||Yoshie, Osamu: 5 articles (04/2006 - 07/2002)|
|2.||Nakayama, Takashi: 5 articles (04/2006 - 07/2002)|
|3.||Lentsch, Alex B: 3 articles (12/2014 - 02/2010)|
|4.||Pritts, Timothy A: 3 articles (12/2014 - 02/2010)|
|5.||Kang, Hee-Kyoung: 3 articles (03/2013 - 12/2012)|
|6.||Kang, Gyeoung-Jin: 3 articles (03/2013 - 12/2012)|
|7.||Han, Sang-Chul: 3 articles (03/2013 - 12/2012)|
|8.||Yoo, Eun-Sook: 3 articles (03/2013 - 12/2012)|
|9.||Endres, Stefan: 2 articles (11/2015 - 11/2011)|
|10.||Bourquin, Carole: 2 articles (11/2015 - 11/2011)|
01/01/2015 - "Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases."
10/15/2008 - "Macrophage-derived chemokine (MDC) CCL22 is a potent chemoattractant for Th2 cells and has been implicated in Th2-predominant allergic inflammation. "
08/01/2007 - "Macrophage-derived chemokine (MDC) is a T-helper cell type 2 (Th2)-related chemokine involved in recruitment of Th2 cells toward allergen-challenged inflammation. "
05/15/2000 - "Macrophage-derived chemokine (MDC), a recently identified CC chemokine, has been regarded to be involved in chronic inflammation and dendritic cell and lymphocyte homing. "
01/01/2003 - "A functional similarity was also found between chronic inflammation and the T-cell zone of lymph nodes (LNs), since a substantial fraction of phenotypically mature DCs in both tissues expressed CCL22 (macrophage-derived chemokine; MDC) and were closely surrounded by memory-type T cells expressing its receptor, CCR4. "
|3.||Ovarian Neoplasms (Ovarian Cancer)
06/01/2015 - "The study was undertaken to evaluate macrophage-derived chemokine (CCL22) levels in the peritoneal fluid (PF) and plasma of patients with ovarian cancer (n = 93) in relation to regulatory T cells (Tregs; n = 75). "
06/01/2015 - "Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients."
|4.||Atopic Dermatitis (Atopic Eczema)
02/28/2011 - "In particular, the macrophage-derived chemokine CCL22 is directly implicated in Th-2-associated skin inflammatory reactions, and its levels are significantly elevated in serum and are correlated with disease severity in atopic dermatitis. "
11/01/2006 - "Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis."
08/01/2003 - "Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children."
02/01/2002 - "Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis."
08/01/2009 - "The macrophage-derived chemokine (MDC/CCL22) is a prototypic Th2-type chemokine intimately involved in Th2-skewed allergic diseases, such as atopic dermatitis and asthma. "
11/01/2015 - "The chemokine CCL22 is abundantly expressed in many types of cancer and is instrumental for intratumoral recruitment of regulatory T cells (Treg), an important subset of immunosuppressive and tumor-promoting lymphocytes. "
11/01/2013 - "In parallel, the Treg-recruiting chemokine CCL22, which is sequestered by D6, was threefold increased in tumor tissue. "
07/01/2010 - "Additionally, increased levels of chemokine CCL22, which mediates migration of Tregs to the tumor, and upregulation of the corresponding receptor protein CCR4 were observed in HNSCC. "
09/15/2007 - "Our previous work showed that tumor-associated macrophages spontaneously produced chemokine CCL22 to mediate Treg cell trafficking into tumor, and Treg cells induced B7-H4 on antigen-presenting cells (APC) including macrophages. "
09/01/2004 - "Tumor cells and microenvironmental macrophages produce the chemokine CCL22, which mediates trafficking of T(reg) cells to the tumor. "
|3.||Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
|7.||Interferon-gamma (Interferon, gamma)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)